C-PVYUNeuroAge Therapeutics
AI cognitive testing, multi-modal diagnostics, brain aging biomarkers
discoverydiscovering
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-PVYU
C-PVYUC-PVYUAI cognitive testing, multi-modal diagnostics, brain aging biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Main Page Courses Main Page Information Timetable Team Registration Personal Status Login Remember me Login Registration Forgot Password? Enable dark mode Enable light mode Software Engineering Research in the Neuroage Prof. Dr. Sven Apel Seminar/Proseminar — Summer Semester 2022 News Grades and Evaluation Online Written on 21.10.22 by Christian Kaltenecker Dear student, We have entered the grades for the seminar 'Software Engineering Research in the Neuroage' in the LSF. Moreover, we have also uploaded the evaluation results for this seminar on the CMS. Thank you … ur presentation via e-mail. At the day of your presentation, you have to submit your final presentation as PDF in the CMS. Please do this already in the morning; in the case that your laptop shouldn't work, we can easily download your presentation and use a laptop from the chair, instead. Schedule for Presentations is online! Written on 10.06.22 by Christian Kaltenecker We will have three sessions for presentations from 23-th of June until 14-th of July 2022. Pleas … presentation and a written thesis. To aid the literature search, the experiment proposal, and the presentation, this seminar includes multiple preparatory sessions at the beginning of the semester. The student presentations will be held in June and July 2022. All sessions will take place on-site at the university (under the caveat that the pandemic situation admits in-person sessions) on Thursdays 12:15 PM - 2:00 PM. Participation to all sessions is mandatory. The topi
SVEC Open House · Luma Discover Events Sign In Presented by Silicon Valley Engineering Council (SVEC) Follow SVEC.org - Calendar of events Hosted By Silicon Valley Engineering Council (SVEC) Ceal Craig Elise Engelhardt Marziya Hasan 99 Went Elise Engelhardt, Jerry Pohorsky and 97 others Contact the Host Report Event Tech SVEC Open House Silicon Valley Engineering Council (SVEC) 810 Kifer Rd Sunnyvale, United States Get Tickets Registration Closed This event is not currently taking registrations. You may contact the host or subscribe to receive updates. About Event Silicon Valley Engineering
SVEC Open House - 2025 - Silicon Valley Engineering Council Skip to content The Alliance for Engineering Leaders in Silicon Valley Home About Menu Toggle About Leadership Sponsor SVEC SVEC Commitees SVEC History Membership Menu Toggle Membership Join SVEC American Society of Mechanical Engineers (ASME – SCVS) Association for Computing Machinery (ACM) Electric Auto Association of Silicon Valley (EAA SV) IEEE – Santa Clara Valley Section SAMPE Society of Manufacturing Engineers – SME Society of Plastics Engineers (SPE) Society of Women Engineers of Santa Clara Valley (SWE SCV) Hall of Fame Menu … Santa Clara Valley (SWE SCV) Hall of Fame Menu Toggle Hall of Fame Nominations Application Programs Menu Toggle Education Outreach High School STEM Education Grants College STEM Education Grants Graduate STEM Education Grant Awardees Keeper of the Flame Award SVEC News Events Menu Toggle SVEC Hall of Fame Ceremony and Awards – 2026 SVEC Open House – 2025 Legends of Engineering SVEC Banquet/Hall of Fame Ceremony 2025 Menu Toggle 2025 Banquet/Hall of Fame Sponsorships SVEC Ban … l of Fame Sponsorships SVEC Banquet/Hall of Fame Ceremony 2024 Menu Toggle STEM Scholarship Awards – 2024 High School STEM Scholarship Awards – 2024 College 2024 Keeper of the Flame Award Contact Main Menu New Pathways to Improve Healthcare Silicon Valley Engineering Council’s annual Open House features networking with refreshments and a Biotech panel discussion, including engineering’s role in healthcare futures. The population in the United States and man … Santa Clara Valley (SWE SCV) Hall of Fame Menu Toggle Hall of Fame Nominations Application Programs Menu Toggle Education Outreach High School STEM Education Grants College STEM Education Grants Graduate STEM Education Grant Awardees Keeper of the Flame Award SVEC News Events Menu Toggle SVEC Hall of Fame Ceremony and Awards – 2026 SVEC Open House – 2025 Legends of Engineering SVEC Banquet/Hall of Fame Ceremony 2025 Menu Toggle 2025 Banquet/Hall of Fame Sponsorships SVEC Ban … l of Fame Sponsorships SVEC Banquet/Hall of Fame Ceremony 2024 Menu Toggle STEM Scholarship Awards – 2024 High School STEM Scholarship Awards – 2024 College 2024 Keeper of the Flame Award Contact Home About Menu Toggle About Leadership Sponsor SVEC SVEC Commitees SVEC History Membership Menu Toggle Membership Join SVEC American Society of Mechani
Propelx Backs NeuroAge Therapeutics in Pre-Seed Funding to Transform Brain Health | Propel(x) Analytics cookies to view the content." data-cli-src="https://www.googletagmanager.com/ns.html?id=GTM-5QB6T3D" height="0" width="0" style="display:none;visibility:hidden" aria-hidden="true"> Skip to content Investors SPV-as-a-Service Startups / Hedge Funds Real Estate Resources Company Portfolio Press Corporate Innovation Blog Newsletter Events Podcast Glossary FAQ Angel Resources Contact Us Login Sign Up Investors SPV-as-a-Service Startups / Hedge Funds Real Estate Resources Company Portfolio Press C … in opportunities posted on the platform and so designated are advised by Planck Fund Management Corporation (“PFMC”), an affiliate of Propel(x), and registered as an exempt reporting advisor with the state of Nevada. PFMC does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform. Privacy Terms Contact Us Linkedin Facebook Twitter
Frontiers | Regional Brain Volume, Brain Reserve and MMSE Performance in Healthy Aging From the NEUROAGE Cohort: Contributions of Sex, Education, and Depression Symptoms Frontiers in Aging Neuroscience About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee policy Services Societies National consortia Institutional partnerships Collaborators More from Frontiers Frontiers For … partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All articles Submit your research Search Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Mov … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee p … partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All articles Submit your research Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Movement D … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Me
200 risk genes for neurodegenerative disorders. It uniquely identifies three distinct types of brain aging: structural, functional, and molecular. Drug Development (Therapeutic Pipeline) The company has an innovative approach to combat neurodegenerative disorders like Alzheimer's by reversing brain aging, leveraging human omics and AI to identify targets causally implicated in brain aging. They use AI to combine the power of tracking individual's brain aging and genetics to create drugs tailored to an individual's biomarkers. NeuroAge was founded by Dr. Christin Glorioso, who witnessed the dev
Exercise Timing and Your Chronotype | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Exercise Timing and Your Chronotype What the science says about when to exercise if you are a morning lark, a night owl, or somewhere in between Dr. Christin Glorioso, MD PhD May 19, 2026 13 min read I have historically been a night owl, and early-morning exercise left me yawning by 10am and depleted for the rest of the day. I wish that this wasn’t the case for me because exercising early,
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Nootropics and neurorestoratives graded by the evidence | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Nootropics and neurorestoratives graded by the evidence Dr. Christin Glorioso, MD PhD May 31, 2026 23 min read The question I get most about brain supplements and drugs is about what works and what people should take. The first thing I want to know about a compound is which of two camps it belongs to, because that distinction shapes what to expect from it and whether th
Statins and Dementia Prevention | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Statins and Dementia Prevention Friend or Foe? Dr. Christin Glorioso, MD PhD January 19, 2025 3 min read TL/DR: Statins do appear to be beneficial for dementia prevention but there was an FDA warning about them in 2012 that caused some bad press . I was surprised recently when a client mentioned that statins might increase risk of Alzheimer’s or other neuro disorders. I recently started taking
Vall d’Hebron coordinates the NEUROAGE network to accelerate the impact of research on ageing and neurodegenerative diseases | VHIR - Vall d'Hebron Institut de Recerca Skip to main content If you want to visit other Campus websites click on the logos Image Image Ves al web Image Image Ves al web Image Image Ves al web Image Image Ves al web Image Image Ves al web ca en es Header links Intranet Donate now image/svg+xml Map Contact us Institute About the VHIR Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research , innovation and teaching . Over 1,800 people are
NeuroAge Therapeutics: Revolutionary Brain Health Test --> Accessibility: Skip TopNav NeuroAge Therapeutics: Revolutionary Brain Health Test Predicts Dementia Risk 30 Years in Advance A Breakthrough Prognostic for Tracking Brain Aging to Maintain Cognitive Resilience November 25, 2024 21:01 ET | Source: NeuroAge Therapeutics NeuroAge Therapeutics SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- NeuroAge Therapeutics unveiled its groundbreaking NeuroAge Test, a comprehensive brain aging assessment that combines advanced AI, MRI technology, genetic and cognitive analysis to predict biolog
Vall d’Hebron coordinates the NEUROAGE network to Skip to main content CA ES EN Menú superior El Meu Vall d'Hebron Intranet Donate now Map Contact Navegació principal About us A leading campus We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management. Institutions Principles Our professionals Work with us Strategic Committee Strategic Projects VHTeDades Socially responsible Accreditations History Corporate documentation Healthcare Healthcare Professionalism, commitment and research by professionals on the Campus are the key el … areas of the health sciences, helping to train the professionals of the future. Residency Teaching units Centre for Advanced Clinical Simulation Training stays Continuous professional development Professional training Alumnus Vall d'Hebron Aula Vall d'Hebron Degrees Master’s and postgraduate degrees Accreditations News News We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.3 %���� 1 0 obj >]/Pages 3 0 R/Type/Catalog/ViewerPreferences >>> endobj 2 0 obj >stream 2026-04-30T23:19:46+05:00 2026-04-30T23:20:17+05:00 2026-04-30T23:20:17+05:00 Adobe InDesign 16.1 (Macintosh) uuid:e0cc4d2e-db1c-424b-acc2-ba6b9fae2803 xmp.did:61ba58ad-1084-b347-970d-c04e4efc6574 xmp.id:3adec794-8492-4fe9-9b0f-ff03bc2faced proof:pdf 1 xmp.iid:858eb888-7e73-4580-aed3-512e43801b6e xmp.did:2540396a-9041-416e-9c81-50c7ad8c45d3 xmp.did:61ba58ad-1084-b347-970d-c04e4efc6574 default converted from application/x-indesign to application/pdf Adobe InDesign 16.1 (Macintosh) / 2026-04-30T23:19: … to application/pdf Adobe InDesign 16.1 (Macintosh) / 2026-04-30T23:19:46+05:00 application/pdf неокончательно. JCMK-02-2026, 30.04.indd Adobe PDF Library 15.0 False PDF/X-1:2001 PDF/X-1:2001 PDF/X-1a:2001 endstream endobj 3 0 obj > endobj 15 0 obj > endobj 16 0 obj > endobj 17 0 obj > endobj 18 0 obj > endobj 34 0 obj > endobj 35 0 obj > endobj 36 0 obj > endobj 37 0 obj > endobj 38 0 obj > endobj 39 0 obj > endobj 40 0 obj > endobj 41 0 obj > endobj 77 0 obj /LastModified / … 299.998694 Millimeters Cyan Magenta Yellow Black Группа образцов по умолчанию 0 application/postscript Bekzat Polat endstream endobj 554 0 obj > endobj 571 0 obj > endobj 572 0 obj >stream H�\��j�0 ��~ �Cq�֔B��� ��e{��V���'=��'E�������%]Vϕ�g��q�5����E��[�-^{�� \o��n�ۡ J��^���w��s� �����ɍ-n�~�cﯰ�*�-����gH�(�aG�4��*�U�����H�w�s ٺO�;:�Bc16��*Oh�_h ���O����~7Q� N *?�+S > ���a> �O�'�R�d> ��/�TLn�˰�Ʉ3��Y| ��5�kċ?�^=?�����[�ԶuTk��S���4��T��_Nא# endstream e … ��EF��q�rf� CįQ9ZY�$r!���6m �)�4� ��V�9�k�J�$#�� Fь�X��٥�C��p�[��ģ)C���S�;rFP#�I�m�K�G ɺ��z���j>>��X�9,�ZL-j��Ib�k��ȉ8�˚?v�t���� �x������P�IO}�_ay@ ��:����|Ve�6�����ubd/e�3 T� Sؓ�7X����?MM�!���Լu�O��t����P Cbt;���i����ް��a��@gW��#�@��4c�9.D���o� z2>M�5��i�~�u0� �q�s �wQ�9�ǸLt��삟�Mz)>���kɝ���I�;���io�"���U)��]$Y���L >� $����$T����:gUo$���UK���,�C�`sCMAJMÄ��K��C(��g]���ٮ9�s�U�G�0?����L�5��� �QM%��0O�l��5&���`�Ƒ 1,��x�'���{��k+�mY�}���
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.5 %���� 4 0 obj > stream x���P(���� endstream endobj 7 0 obj > stream x���P(���� endstream endobj 9 0 obj > stream x���P(���� endstream endobj 11 0 obj > stream x���P(���� endstream endobj 17 0 obj > stream x���P(���� endstream endobj 20 0 obj > stream x���P(���� endstream endobj 23 0 obj > stream x���P(���� endstream endobj 26 0 obj > stream x���P(���� endstream endobj 29 0 obj > stream xڭ�T� ��̤��"��7 M �HoR��JH�!�� � �(""�(�*₫+ kE �`��YT�uq*;�sV�{�����͙���������sj7G�&�QDb�$*��OHD�r@�"P: nnv���h�)����B� �f@��{R��s�@Io�fK���8�'���1 … etter, pamphlet. url URL external URL for the article or unit of content pdfTeX application/pdf 2 B LaTeX with hyperref 2022-07-26T09:02:23+02:00 2022-07-26T09:02:23+02:00 2022-07-26T09:02:23+02:00 uuid:55FB8A94-A80A-963A-F0C8-07BE6A8D6238 uuid:949C396A-C4EA-B494-5D16-462ADDED05DA endstream endobj 38 0 obj > stream xڕTKs� ��WpD3��-ͫ�L2i㶇N��e&r����ҿ^�ũ�d�d8�~�߾����q������Ჿ���������H&r��p�����OIr����w�ǀ ��Y�2t�L>�� ���u�����LbQ ��|��$�I$UND�����GQ̹�w�����ʚ� ����% … f���ǎ,լ� �A�XZ �(�������$6�YX�0J,բN�@w N��J=���h��u�ì�1�T+RfP�� > 䊁�Z�����`�U�� ��������ڂOm��t��X�Y���j���Om��P�0�a�¬yfIf�Q[�Y:g ,�,P�t�0��C�� vu�`�ac� TfXG�L���x䑕Z���1��� �x�����Y}`PîI`��B- yd�h ����l�-!���C���T��ł�0�^�@%� ���x@��KQ��n/|Ri�^@��}�r����}�� �[�u�'�H1����,���S�D&�@����h�jK�?� S�T f�a@}_� VA2ԭ�KF�X3J�ʶt����}�����UR�[A��m �����}Y���/n.�z�wmD�ƨ�- ��nl�P{ׂ@�F�A�De`P��Y�tt^ՌA�F8
WeMind Cluster joins the NEUROAGE network to drive innovation in aging and neurodegenerative diseases – WeMind Cluster Skip to content longevity Neuro Mental Health Menu Menu The Cluster The Cluster Board of Directors Team Cluster Transparency WeMind Tools WeMind Forum Brain Journal Call MindExcellence MindSyst Projects Projects Financing opportunities Find your partner Task Force AEI aid Project office News & Events News Events Calendar international WeMind Forum International missions Our partners Become a member Members area CA CA EN ES WEMIND NEWS WeMind Cluster joins the NEUROAGE netw
%PDF-1.3 %���� 871 0 obj > endobj xref 871 47 0000000016 00000 n 0000004405 00000 n 0000004534 00000 n 0000005008 00000 n 0000005287 00000 n 0000005362 00000 n 0000005441 00000 n 0000010808 00000 n 0000011243 00000 n 0000011297 00000 n 0000011723 00000 n 0000011809 00000 n 0000012050 00000 n 0000015916 00000 n 0000016265 00000 n 0000020943 00000 n 0000025522 00000 n 0000030566 00000 n 0000035774 00000 n 0000040673 00000 n 0000041202 00000 n 0000041737 00000 n 0000042249 00000 n 0000042317 00000 n 0000042371 00000 n 0000042549 00000 n 0000044751 00000 n 0000045026 00000 n 0000049264 00000 n 000 … ��Z��L7���1��5|�u���.t8�czu���@o"�b ̡>����,D����!t� \����sa>� ���s�RFp!���q���4��ߩ�`�" ��3`�( v�ҠQ� �4�)I�7%�[�V��[�Lh�e���th�gB�)֙P`������l��S� ]�ǿ�J��GTR,��,����/_�;�d��ʪu��kMW�2�o�`�{y=P���_��{cK���&_�� ���:�����;/m�v��#�\Yk8V�B�g����,/B�n:,x��wa�8�� F����� =l�P:N���u {O��9�$W��?y]�=yU��� Ѧ �S�y�NdݳZB�� �rk��8���HRNa}pB�����O����2s�NI\C��ܽJL Q$~�U||\�m�!T�Q5�vd��{�����i��*�9�nޯ�� U��aup�����/ź� ���7�l��ƎiZ�&O8�U ��g� … dobj 864 0 obj > endobj 865 0 obj > endobj 866 0 obj > endobj 867 0 obj >stream application/pdf 230839 Venture Life cover 10mm mac False PDF/X-1:2001 PDF/X-1a:2001 Acrobat Distiller 8.0.0 (Macintosh) 2014-03-24T22:31:09Z 2014-03-25T00:46:29Z QuarkXPress 8.5.1 2014-03-25T00:46:29Z uuid:8ad9a21b-5555-674d-9fe0-df86d949f905 uuid:7a1f0f65-63d9-47d5-8d7b-fecb6c5e36f2 endstream endobj 868 0 obj > endobj 869 0 obj >stream h�|�uT�ͻ�AA)AQ@AT@I�Ii��k����N6��4l�;E@l�^ ������
%PDF-1.7 %���� 1684 0 obj > endobj xref 1684 188 0000000016 00000 n 0000006950 00000 n 0000007085 00000 n 0000009277 00000 n 0000009812 00000 n 0000010251 00000 n 0000010551 00000 n 0000010920 00000 n 0000011403 00000 n 0000011442 00000 n 0000011557 00000 n 0000012033 00000 n 0000012621 00000 n 0000012746 00000 n 0000013017 00000 n 0000013277 00000 n 0000013532 00000 n 0000014099 00000 n 0000020492 00000 n 0000028254 00000 n 0000036047 00000 n 0000036172 00000 n 0000036287 00000 n 0000036413 00000 n 0000043328 00000 n 0000051231 00000 n 0000058939 00000 n 0000065978 00000 n 0000074356 00000 n … ��,���� )Ԑ���s�ɗ��6����cW�dp�64Q��%���rlC6������[��OU��zxw=rچC����?t� >stream application/pdf LSN Logo 2022-08-30T13:41:09-04:00 2022-08-30T13:41:09-04:00 2022-08-30T13:41:09-04:00 Adobe Illustrator 26.3 (Windows) uuid:4f5ba327-632d-4d3e-9750-3dbb5ac53375 xmp.did:08a59ab9-3855-0341-99ff-96f16744b3b7 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:b8b627b9-63dc-f348-9625-1ed948e71f30 xmp.did:b8b627b9-63dc-f348-9625-1ed948e71f30 uuid:5D20892493BFDB11914A8590D31508C8 d … Adobe PDF library 16.07 endstream endobj 1723 0 obj > endobj 1724 0 obj >stream application/postscript POLSINELLI-TAGLINE (Kelly Ludwig) 2023-12-11T09:48:12-06:00 2023-12-11T09:48:12-06:00 2023-12-11T09:48:12-06:00 Adobe Illustrator 28.0 (Macintosh) xmp.iid:b17b322d-6435-4a3e-a4ae-5611e5ee8738 xmp.did:04150ed5-a00d-4602-a0dc-3bf2c2dce1dc uuid:5D20892493BFDB11914A8590D31508C8 default xmp.iid:8977f143-08ef-46b7-9cc6-fd85c3913a9e xmp.did:273aad7b-7c2c-4234-9706-4fb26a471748 uuid … 1 2023-12-08T08:59:07-06:00 Adobe Illustrator 28.0 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:273aad7b-7c2c-4234-9706-4fb26a471748 2023-12-10T16:10:51-06:00 Adobe Illustrator 28.0 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator s … 00000 0.003100 0.003100 endstream endobj 1725 0 obj > endobj 1726 0 obj >stream application/pdf RESI Global 2025-08-11T15:19:37-04:00 2025-08-11T15:19:37-04:00 2025-08-11T15:19:37-04:00 Adobe Illustrator 29.4 (Windows) uuid:a7a8c2f4-ed61-49fe-90cd-09bca9c4c51d xmp.did:fe4887cc-ebf3-b940-a98c-c8f65c30ee46 uuid:5D20892493BFDB11914A8590D31508C8 proo
The PCSK9 longevity gene- therapeutics, heart health, brain health, and supplements | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog The PCSK9 longevity gene- therapeutics, heart health, brain health, and supplements Dr. Christin Glorioso, MD PhD November 7, 2025 15 min read The story of PCSK9 (proprotein convertase subtilisin/kexin type 9) is one of the most remarkable examples of translational medicine in the 21st century. In just over two decades, this protein went from
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
BRAIN RESEARCH EN English Deutsch Français Español Português Italiano Român Nederlands Latina Dansk Svenska Norsk Magyar Bahasa Indonesia Türkçe Suomi Latvian Lithuanian český русский български العربية Unknown Login to YUMPU News Login to YUMPU Publishing TRY ADFREE Discover products News Publishing Magazines Create ePaper Login to YUMPU News Login to YUMPU Publishing × Attention! Your ePaper is waiting for publication! By publishing your document, the content will be optimally indexed by Google via AI and sorted into the right category for over 500 million ePaper readers on YUMPU. This
How to reverse your brain aging | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog How to reverse your brain aging What we know from the scientific literature Dr. Christin Glorioso, MD PhD January 9, 2025 11 min read I was surprised that the number one question that people ask when I talk to them about NeuroAge is “how do I reverse my brain aging?” This shouldn’t have come as a surprise as I would have asked the same thing if I hadn’t been reading scientific papers for 20 ye
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram Instagram Log In Sign Up Close Never miss a post from biogen_global Sign up for Instagram to stay in the loop. Sign up Log in biogen_global • Follow More options biogen_global 9w We’re celebrating the expansion of our West Coast Hub in South San Francisco, reinforcing the foundation for our growing immunology pipeline. This newly expanded site is a key part of Biogen’s global R&D ecosystem to build sustainable growth. As we continue to invest in the Bay Area, we look forward to building on our legacy and working closely with local partners to help accelerate scientific innovation
ACRM Program | RehabWeek 2022 , --> Congress Information Welcome Letter About RehabWeek General Information Committees REHABWEEK STEERING COMMITTEE FURTHER MEMBERS OF THE REHABWEEK ORGANIZING COMMITTEE ICORR 2022 IFESS 2022 INRS 2022 ISVR 2022 ACRM 2022 ISPO-NL 2022 NSRM 2022 MiNT 2022 Key Dates Contact Us Society Information ACRM - The American Congress of Rehabilitation Medicine ICORR - International Consortium for Rehabilitation Robotics IISART - The International Industry Society in Advanced Rehabilitation Technology IFESS - International Functional Electrical Stimulation Society ISPO-NL: … hn Quarles RehabWeek Panel Discussions Abstract & Paper Submission / Poster Award Oral Presentations Fast Forward Poster & Poster Presentations Clinic and Lab Visits Registration & Accommodation Registration Accommodation Sponsorship & Exhibition Sponsorship & Exhibition Opportunities Sponsorship & Exhibition Prospectus Online Booking Portal Floorplan Exhibitor Technical Manual Past Sponsors and Exhibitors Confirmed Sponsors Platinum Sponsors Useful Li … k Speakers RehabWeek Panel Discussions Abstract & Paper Submission / Poster Award Oral Presentations Fast Forward Poster & Poster Presentations Clinic and Lab Visits TUESDAY, JULY 26, 2022 Session 1: Big Data / 11:45 - 13:15 Title: Integrating Data and Metrics into Clinical Practice Presenters: Pamela Roberts, Jeffrey Wertheimer Title: Association of functional recovery with occupational therapy time and content for inpatient adults with acquired brain injury us … k Speakers RehabWeek Panel Discussions Abstract & Paper Submission / Poster Award Oral Presentations Fast Forward Poster & Poster Presentations Clinic and Lab Visits Congress Information Society Information Scientific Information Registration & Accommodation Sponsorship & Exhibition Useful Links © RehabWeek 2022. All Rights Reserved by | Privacy Policy | Cookie Policy
Vall d’Hebron coordinates the NEUROAGE network to Skip to main content CA ES EN Menú superior El Meu Vall d'Hebron Intranet Donate now Map Contact Navegació principal About us About us We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role. Centers Organisational model Professionals Management team Nursing care Accreditations 70 years A socially responsible ho
NeuroAge Partners with Phoenix Community for APOE4 Carriers | Christin Glorioso, MD PHD posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or
Join us for Symposium 2026, where the... - Logan University Facebook Log In Logan University's Post Logan University December 29, 2025 · Shared with Public Join us for Symposium 2026, where the brightest minds in chiropractic and health sciences come together! Introducing our main speakers: Daniel J. Murphy, DC, DABCO Brad Beira, MTech F, ICSSD, BCom Law, LLM Cindy Howard, DC, DABCI, FIAMA, FICC Annette Kutz Schippel, DC ('98) Brian Jensen, DC Alan Sokoloff, DC With more than 40 leading experts, you'll gain practical strategies, cutting-edge insights and actionable tips that can
NeuroAge Therapeutics Closes Pre-Seed Extension Round with R42 Group | Christin Glorioso, MD PHD posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to … eatic neuroendocrine tumors (PanNETs) resist treatment? NETRF Mentored Research Award recipient Yeonghwan Kim , PhD, Postdoctoral Fellow at Columbia University Irving Medical Center , is working hard to answer that question. 🔬Dr. Kim’s team discovered that a protein called VEGF-C may help tumors bypass therapies that cut off their blood supply. This research expands possibilities for more personalized treatments that could slow tumor growth, reduce liver metastases, and impr
NeuroAge Therapeutics: How Tech Fights Dementia with Yuriy Golikov | Christin Glorioso, MD PHD posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to j
Why I founded NeuroAge Therapeutics | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Why I founded NeuroAge Therapeutics A personal journey in Alzheimer's prevention Dr. Christin Glorioso, MD PhD January 3, 2025 7 min read When I was a kid my grandmother suffered with Alzheimer’s and my grandfather took care of her in their home. It started in her late 60s, and lasted for about 7 years before she eventually passed. It devastated the whole family, most of all my grandf … f the lack of actionability for Alzheimer’s clinically, I opted not to pursue a residency in neurology or psychiatry, which was my original plan. I instead went to MIT to pursue a postdoc in the renowned aging biology lab of Professor Lenny Guarente. There I continued my research on human brain aging, collaborating back with my PhD advisor and forging new connections. Although I love MIT, I became disenchanted with academia during my postdoc. It seemed like the incentives wer
Mile High Noon SPEAKERS AGENDA EVENT DETAILS SPONSORS HOTEL ROOTIN-TOOTIN' AFTER PARTY Mile High Noon SPEAKERS AGENDA EVENT DETAILS SPONSORS HOTEL ROOTIN-TOOTIN' AFTER PARTY Mile High Noon The Biggest Chiropratic Event In The West | Change more SPINES, LIVES and MINDS September 26 - 29, 2024 · Delta Hotels by Marriott Denver, Thornton Speakers Daniel Knowles Host Richelle Knowles Host Patrick Gentempo Donny Epstein Eliza Lavin Bobby Findley Tim Young Kimberly Thor-Adams Jay Komarek Amy Spoelstra Ryan Rieder Liz Anderson-Peacock David Fletcher Stephanie Libs Michelle
Instagram Instagram Log In Sign Up Close Never miss a post from parsleyhealth Sign up for Instagram to stay in the loop. Sign up Log in parsleyhealth Verified • Follow More options parsleyhealth Verified 20w Still reflecting on our Longevity Salon event in our NYC center recently! We were excited to gather clinicians, founders, investors, and operators for an intimate panel on what’s emerging in the longevity space. Attendees heard from Parsley Founder and CEO @robinberzinmd , @dr.kuo (Founder & CEO, Extension Health), and @anjula_acharia (Founder & CEO, A-Series Investment and Managem
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram Instagram Log In Sign Up Close Never miss a post from genscriptbiotechcorp Sign up for Instagram to stay in the loop. Sign up Log in genscriptbiotechcorp Verified • Follow More options genscriptbiotechcorp Verified 28w 🌟 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗡𝗲𝘅𝘁 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗼𝗿𝘀 GenScript is honored to support cutting-edge research at 𝗬𝗮𝗹𝗲 𝗣𝗶𝘁𝗰𝗵𝗙𝗲𝘀𝘁 𝟮𝟬𝟮𝟱, providing in-kind research services that help early-stage investigators advance their work, including DNA synthesis, protein expression, cell and gene editing reagen … ogress in life-changing therapeutics. We are excited to recognize the following award recipients and their innovative projects: ✨ 𝙋𝙞𝙩𝙘𝙝𝙁𝙚𝙨𝙩 𝘼𝙬𝙖𝙧𝙙𝙚𝙚𝙨 • Sam Katz, MD, PhD, Associate Professor of Pathology — 𝘕𝘢𝘯𝘰𝘣𝘰𝘥𝘺 𝘔𝘌𝘛 𝘊𝘈𝘙 𝘍𝘰𝘳 𝘚𝘰𝘭𝘪𝘥 𝘛𝘶𝘮𝘰𝘳𝘴 • Roel Verhaak, PhD, Harvey and Kate Cushing Professor of Neurosurgery — 𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘪𝘯𝘨 𝘢𝘯 𝘈𝘋𝘊 𝘧𝘰𝘳 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘰𝘧 𝘎𝘭𝘪𝘰𝘮𝘢 • Sreeganga Chandra, PhD, Professor of Neurolo
Neurorights: Is the creation of new human rights effective in protecting human dignity from the misuse of neurotechnology? | International Bar Association Previous Next Search... Sign in Search... About Contact the IBA About the IBA Governance, leadership and management Task forces Special projects fund Charitable trusts Past presidents Committees / Divisions Legal Practice Division Public and Professional Interest Division Committee index Section index Regional fora Bar Issues Commission Diversity & Inclusion Council Professional Wellbeing Commission Outreach Human Rights Institute High Level … vil Code proposed the inclusion of neurorights in the Brazilian Civil Code. The proposal for this legislative update with a focus on digital law aims to position Brazil at the forefront of protecting human rights in the digital age. While there is no specific regulation on the subject, an alternative would be to interpret neural data as sensitive personal data, under the terms of Article 5, II, of the General Personal Data Protection Law. In fact, perhaps this interpretation
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Home lifespan | Lifespan Research Institute Go Popular Keywords Categories No Record Found View All Results Login Donate Go Popular Keywords Categories No Record Found View All Results Login About Mission Board of Directors Scientific Advisory Board Team Annual Reports Contact Research Supported Projects Investments Publications Education Summer Scholars Post-Baccalaureate Host Lab Signup News Outlet Investor Network About Join Reports Advocacy Video Initiatives Engaging the Press Crowdfunding Sponsored Projects Advocacy Topics A4LI Resources Rejuvenation Roadmap Infographics Longevity Topics
Batch 17 – Berkeley SKYDECK Top Right corner APPLY PARTNERS ABOUT Team & Ambassadors Faculty Advisors Media SkyDeck News Media Kit Students ACE Program Intern Scholarship Virtual Intern Fair Campus Partnerships PROGRAMS Berkeley SkyDeck ADVISORS JOBS NEWSLETTER INVESTORS COMPANIES Portfolio PARTNERS ABOUT Team & Ambassadors Faculty Advisors Media SkyDeck News Media Kit Students ACE Program Intern Scholarship Virtual Intern Fair Campus Partnerships PROGRAMS Berkeley SkyDeck ADVISORS JOBS NEWSLETTER INVESTORS COMPANIES Portfolio BATCH 17 DEMO DA
- LONGEVITY GLOBAL Skip to content LONGEVITY GLOBAL SF | NYC | UAE | BOS | SD | ATX | CO | HYD | CHI | LON | PHX | LA | DEU Menu + × expanded collapsed Events Calendar of longevity events Brain Optimization Summit 2026 Longevity Global Summit 2026 AI x Longevity Summit (NYC) Aging Code Summit 2026 Longevity Innovation Forum (SD) Event Photos Community Become a member Community Chapters Longevity CO Longevity SF Longevity SD Longevity NYC Longevity BOS Longevity Global ATX Longevity CHI Longevity MEL Longevity DEU Longevity LON Resources About Substack YouTube Discount Marketplace Jobs Bo … or government representative. Interested in showcasing your products/services? Apply to Sponsor OUR SPEAKERS See below for our confirmed speakers for 2026. More speaker updates coming soon! Paola Telfer Founder & CEO Sens.ai Antonio Forenza, PhD Founder and CEO AWEAR Laura Glickman, PhD Co-founder & CEO Adjuvia Therapeutics Mike Olson Chairman Of The Board Cityside Journalism Initiative Natalise Kalea Robinson Co-Founder & CEO Parallel Health Ronjon Nag, PhD Pres
We are honored to have the opportunity to present Yunara Life at the Buck Institute for Research on Aging during next week's Longevity Global Summit, alongside such amazing companies innovating in… | Erika Chen LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at
Instagram Instagram Log In Sign Up Close Never miss a post from mavi_facmed Sign up for Instagram to stay in the loop. Sign up Log in mavi_facmed • Follow More options mavi_facmed 9w 🔬🌍 En MAVI nos entusiasma compartir historias que reflejan cómo la ciencia puede cruzar fronteras y transformar trayectorias como fue el caso de Zyanya Zamora en el Instituto Pasteur, Francia. ✨ 🇫🇷 💬 “Desde pequeña, creciendo en un hogar científico, siempre he admirado a figuras como Louis Pasteur. En enero de este año, tuve la oportunidad de participar en el curso “Fundamental Immunology” en el Instituto Pas
Dr. Christin Glorioso - The San Francisco Family Office & High Net Worth Conference Home Agenda About Speakers Past conferences Gallery Sponsorship Testimonials Contact us Follow Us Newsletter LinkedIn Facebook Twitter Stay in Touch Contact Us 1-855-513-1113 [email protected] 4 World Trade Center, 150 Greenwich St, FL 29, New York, NY 10007 Register Now { "name":"The Limassol Family Office Conference", "description":"The Limassol Family Office Conference", "startDate":"2025-11-11", "endDate":"2025-11-11", "startTime":"08:00", "endTime":"18:00", "options":[ "Apple", "Google", "iCal", "Mic
Δεν βρέθηκε η σελίδα που ζητήσατε. Εργαλεία προσβασιμότητας Αλλαγή χρωμάτων Μονόχρωμο Σκοτεινή αντίθεση Φωτεινή αντίθεση Χαμηλή αντίθεση Ψηλή αντίθεση Σήμανση συνδέσμων Επισήμανση τίτλων Αναγνώστης οθόνης Περισσότερα Κλιμάκωση περιεχομένου 100 % Μέγεθος γραμματοσειράς 100 % Διάστημα γραμμής 100 % Απόσταση γραμμάτων 100 % Αναζήτηση... Επιλέξτε τη γλώσσα σας EL EL EN Αρχική ΔΙΠΑΕ ΔΙΠΑΕ Ποιοι είμαστε; Το Συμβούλιο To Προσωπικό Πολιτικές Κώδικας Δεοντολογίας και απουσία Σύγκρουσης Συμφερόντων Δήλωση Πολιτικής Ποιότητας Πολιτική Απορρήτου ΔΙΠΑΕ Διαδικασία Ενστάσεων – Υποβολή και Εξέταση Δήλωση Περι
NeuroAge Therapeutics: A New Approach to the War on Neurological Disease - Spannr Subscribe Marketplace Cold Plunge Red Light Therapy Sauna All Listings Insights Longevity 101 Longevity Funding Report All Longevity Articles Data Companies Investors Glossary Stock Index Ventures Spannr+ Your gateway to the world of longevity Longevity Jobs Find a job in longevity / Find candidates to hire Get the Spannr Newsletter Weekly insights into the future of longevity Sign Up Login About Us Terms of Use Privacy Policy Contact Sign Up For Our Newsletter Weekly insights into the future of longevity Don't w … p; After completing my degrees, I made the unusual move to not pursue a medical residency but instead continue working on my thesis project as a postdoc at MIT in the lab of Lenny Guarente . I was convinced that aging clocks and genetics were the way forward to create new drugs for Alzheimer’s and pursuing a postdoc was the fastest way to continue my research. I set up a large multi-institutional collaboration with labs at Harvard, the Broad Institute, Rush medical cent … e our NeuroAge Test, which will create revenue that can be leveraged along with grant funding to help develop our long-term revenue from approved drugs. We are also excited about strategic partnerships with larger pharmaceutical companies for co-developing drugs, which will diversify our therapeutic strategies and allow us to move more quickly. Taking a step back to look at the larger picture, we need to bring public awareness to longevity and demonstrate that it
LET Reviewer Online Philippines | which of the ff. learning theories explained on ZPD wherein the gap between actual and potential development should be mediated
How to Decrease Your Late Stage Cancer Risk from 20% to 2% | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog How to Decrease Your Late Stage Cancer Risk from 20% to 2% Dr. Christin Glorioso, MD PhD March 1, 2026 17 min read In 2003, Steve Jobs was diagnosed at age 48 with a pancreatic neuroendocrine tumor, a rare and slower-growing form of pancreatic cancer. His tumor was found by accident on a CT scan for kidney stones. At diagnosis it had not spread, and this type of tumo
%PDF-1.3 %���� 1 0 obj >]/Pages 3 0 R/Type/Catalog/ViewerPreferences >>> endobj 2 0 obj >stream uuid:ebd66cbc-e353-4840-9e27-075500733a78 adobe:docid:indd:b1bbd39f-455e-11df-9a17-9a0ce5827041 xmp.id:eafb5122-e79b-4082-a17f-fe8bb342cd88 proof:pdf 1 xmp.iid:245be436-7b49-428e-95c4-a657a32b0e0e xmp.did:affb68a1-4177-416f-ab4b-9dd49fa2d95c adobe:docid:indd:b1bbd39f-455e-11df-9a17-9a0ce5827041 default converted from application/x-indesign to application/pdf Adobe InDesign CC 2017 (Macintosh) / 2019-05-17T15:34:56+01:00 2019-05-17T15:34:56+01:00 2019-05-17T15:35:13+01:00 2019-05-17T15:35:13+01:00 Ad … -17T15:35:13+01:00 2019-05-17T15:35:13+01:00 Adobe InDesign CC 2017 (Macintosh) application/pdf IC_Alpha_VentureLife_Simon_1705.indd Adobe PDF Library 15.0 False PDF/X-1:2001 PDF/X-1:2001 PDF/X-1a:2001 endstream endobj 3 0 obj > endobj 6 0 obj > endobj 7 0 obj > endobj 8 0 obj > endobj 9 0 obj > endobj 25 0 obj >/ExtGState >/Font >/ProcSet[/PDF/Text/ImageC/ImageI]/XObject >>>/TrimBox[8.50394 8.50394 603.78 850.394]/Type/Page>> endobj 26 0 obj >/Font >/ProcSet[/PDF/Text]/XObje … �T��a82F�85[�>� '�U��r3Tj� F�{���x����� {���^x�� > endobj 81 0 obj >stream application/pdf Alpha_assets_final_3mmBleed 2018-02-22T10:12:17Z 2018-02-22T10:12:17Z 2018-02-22T10:12:17Z Adobe Illustrator CC 2015 (Macintosh) uuid:aee21efd-e21b-3041-9ab5-fffa3711a206 xmp.did:694650c2-909c-48e5-8a3f-76b033f0be56 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:562471e4-5d72-0441-af41-c118d3ba16d0 xmp.did:78aa56aa-2d45-41c0-8699-c0143cdc4361 uuid:5D20892493BFDB11914A8590D315 … endobj 316 0 obj >stream endstream endobj 313 0 obj > endobj 318 0 obj >stream application/pdf Alpha_assets_final_3mmBleed 2018-02-22T10:12:17Z 2018-02-22T10:12:17Z 2018-02-22T10:12:17Z Adobe Illustrator CC 2015 (Macintosh) uuid:aee21efd-e21b-3041-9ab5-fffa3711a206 xmp.did:694650c2-909c-48e5-8a3f-76b033f0be56 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:562471e4-5d72-0441-af41-c118d3ba16d0 xmp.did:78aa56aa-2d45-41c0-8699-c0143cdc4361 uuid:5D20892493BFDB11914A8590D315 … �b����座���$���� �x8 endstream endobj 311 0 obj > endobj 319 0 obj >stream application/pdf Alpha_assets_final_3mmBleed 2018-02-22T10:12:17Z 2018-02-22T10:12:17Z 2018-02-22T10:12:17Z Adobe Illustrator CC 2015 (Macintosh) uuid:aee21efd-e21b-3041-9ab5-fffa3711a206 xmp.did:694650c2-909c-48e5-8a3f-76b033f0be56 uuid:5D20892493BFDB11914A8590D31508C
Terms & privacy policy | NeuroAge Therapeutics ← Go back Terms and conditions These terms and conditions outline the rules and regulations for the use of NeuroAge Therapeutics, Inc.'s Website, located at www.neuroagetx.com. By accessing this website we assume you accept these terms and conditions. Do not continue to use NeuroAge Therapeutics, Inc. if you do not agree to take all of the terms and conditions stated on this page. The following terminology applies to these Terms and Conditions, Privacy Statement and Disclaimer Notice and all Agreements: 'Client', 'You' … ess or custom or present commercial activities or unlawful activity. You hereby grant NeuroAge Therapeutics, Inc. a non-exclusive license to use, reproduce, edit and authorize others to use, reproduce and edit any of your Comments in any and all forms, formats or media. Hyperlinking to our content The following organizations may link to our Website without prior written approval: Government agencies; Search engines; News organizations; Online directory distributors may link t … rty privacy policies NeuroAge Therapeutics, Inc.'s Privacy Policy does not apply to other advertisers or websites. Thus, we are advising you to consult the respective Privacy Policies of these third-party ad servers for more detailed information. It may include their practices and instructions about how to opt-out of certain options. You can choose to disable cookies through your individual browser options. To know more detailed information about cookie management with s
Cognitive Decline Interventions LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Skip to main content LinkedIn Top Content People Learning Jobs Games Join now Sign in Top Content Science Cognitive Neuroscience Developments … rof Dr Sunil Kumar FCAI FRSA FBSLM FAcadMEd Dip IBLM Founder|Academic Director |Award-Winning Lifestyle Medicine Driven Longevity Physician| Imperial College | Harvard |Forbes Executive Health Coach |Author | Global Educator & Keynote Speaker| Innovation |IWBI WELL Faculty 5,491 followers 2y Report this post 📢 New Breakthrough in Alzheimer’s Prevention! 🌿🧠 As a lifestyle medicine physician, I’m thrilled to share some groundbreaking findings from a recent study led by D
The Top 25 Supplements for the Brain | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog The Top 25 Supplements for the Brain Dr. Christin Glorioso, MD PhD September 9, 2025 2 min read The number one question that I get from people is “what supplements would you recommend?”. And relatedly, “what is your stack”? I don’t really take that many supplements. I take a multi-vitamin and some prescribed medications. I’m risk averse when it comes to putting things into my body and con
Tomorrow on the Good Medicine Podcast, Dr. Christin Glorioso from NeuroAge explains how their brain-age test works and how personalized recommendations can help you start reversing brain aging. | Biolexis Therapeutics, Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your ch
How to Stay Sharper Longer: Th... - The TechEd Podcast - Apple 播客 搜索 主页 新发现 排行榜 搜索 3月31日 47 分钟 How to Stay Sharper Longer: The New Science of Brain Aging - Dr. Christin Glorioso, CEO of NeuroAge Therapeutics The TechEd Podcast 播放 Imagine being able to track your brain health before serious decline sets in, understand your personal risk factors, and intervene early enough to help prevent dementia rather than simply react to it. In this episode of The TechEd Podcast , Matt Kirchner talks with Christin Glorioso, MD, PhD, founder and CEO of NeuroAge Therapeutics, about one of the most intriguing f
Instagram Instagram Log In Sign Up Close Never miss a post from neuroage_therapeutics Sign up for Instagram to stay in the loop. Sign up Log in neuroage_therapeutics • Follow More options neuroage_therapeutics 62w Today is NeuroAge Therapeutics’s third birthday 🎂 🎉 🎉 What a ride it’s been. We launched the NeuroAge Test for brain aging, which uses AI to combine brain MRI, cognitive testing, and our proprietary transcriptome brain aging clock to help people track their brain aging and prevent dementia in the future. The NeuroAge Test is now available in clinics and to consumers in the US, Can
Reverse Brain Aging with Dr Christin Glorioso on NeuroAge Therapeutics | The TechEd Podcast posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join
How to Stay Sharper Longer: The New Science of Brain Aging - Dr. Christin Glorioso, CEO of NeuroAge Therapeutics - The TechEd Podcast | iHeart Your Library Podcasts News All Episodes How to Stay Sharper Longer: The New Science of Brain Aging - Dr. Christin Glorioso, CEO of NeuroAge Therapeutics March 31, 2026 • 46 mins Imagine being able to track your brain health before serious decline sets in, understand your personal risk factors, and intervene early enough to help prevent dementia rather than simply react to it. In this episode of The TechEd Podcast , Matt Kirchner talks with Christin Glor
Reverse Brain Aging & Personal… — Good Medicine Podcast — Apple Podcasts Buscar Início Novidades Top charts Buscar 25 de novembro de 2025 52 min Reverse Brain Aging & Personalized Science | Dr. Christin Glorioso Good Medicine Podcast Reproduzir This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Christin Glorioso of NeuroAge to explore new ideas in brain health and aging. Dr. Glorioso explains how NeuroAge’s comprehensive test measures your brain’s “age” and provides personalized recommendations to help you work toward reversing brain aging. She also talks about
How to Stay Sharper Longer: The New Science of Brain Aging and Dementia Prevention - Dr. Christin Glorioso, CEO of NeuroAge Therapeutics - The TechEd Podcast Skip to content Main Menu About Episodes Menu Toggle View all Episodes Ask Us Anything Blog Contact Subscribe Subscribe How to Stay Sharper Longer: The New Science of Brain Aging Dr. Christin Glorioso, CEO and Co-founder of NeuroAge Therapeutics Love the episode? Leave a review on your favorite podcast platform! ⭐⭐⭐⭐⭐ Imagine being able to track your brain health before serious decline sets in, understand your personal risk factors, and i
The King's Birthday Honours 2026 Overseas and International List: Order of the British Empire | zixuan an LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in,
%PDF-1.4 %���� 8467 0 obj > endobj xref 8467 180 0000000016 00000 n 0000007535 00000 n 0000007721 00000 n 0000012727 00000 n 0000013292 00000 n 0000013853 00000 n 0000013933 00000 n 0000014048 00000 n 0000014581 00000 n 0000015200 00000 n 0000015313 00000 n 0000015403 00000 n 0000015994 00000 n 0000016631 00000 n 0000016730 00000 n 0000016898 00000 n 0000020671 00000 n 0000025976 00000 n 0000031347 00000 n 0000036237 00000 n 0000036362 00000 n 0000036487 00000 n 0000036613 00000 n 0000036738 00000 n 0000036853 00000 n 0000041502 00000 n 0000041773 00000 n 0000042033 00000 n 0000042333 00000 n … 8511 0 obj > endobj 8512 0 obj > endobj 8513 0 obj > endobj 8514 0 obj >stream application/pdf RESI Full 2022-08-30T13:23:11-04:00 2022-08-30T13:23:11-04:00 2022-08-30T13:23:10-04:00 Adobe Illustrator 26.3 (Windows) uuid:166d2bf4-d4d5-4dba-af2c-9687b1393474 xmp.did:b8b627b9-63dc-f348-9625-1ed948e71f30 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:40f0d353-75a6-694e-b6ea-5f797d1823ba xmp.did:40f0d353-75a6-694e-b6ea-5f797d1823ba uuid:5D20892493BFDB11914A8590D31508C8 … Adobe PDF library 16.07 endstream endobj 8515 0 obj > endobj 8516 0 obj >stream application/pdf RESI Global 2022-08-30T12:44-04:00 2022-08-30T12:44-04:00 2022-08-30T12:43:59-04:00 Adobe Illustrator 26.3 (Windows) uuid:bf1c6c4b-8c94-4f4f-9641-634d66e081c8 xmp.did:40f0d353-75a6-694e-b6ea-5f797d1823ba uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:d1c078a0-2746-42b2-b0d1-25aedff8fb1e xmp.did:1b6690ed-28a8-c141-9479-b6a9cf6be651 uuid:5D20892493BFDB11914A8590D31508C8 proof:p … Adobe PDF library 16.07 endstream endobj 8517 0 obj > endobj 8518 0 obj >stream application/pdf LSN Logo 2022-08-30T13:41:09-04:00 2022-08-30T13:41:09-04:00 2022-08-30T13:41:09-04:00 Adobe Illustrator 26.3 (Windows) uuid:4f5ba327-632d-4d3e-9750-3dbb5ac53375 xmp.did:08a59ab9-3855-0341-99ff-96f16744b3b7 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:b8b627b9-63dc-f348-9625-1ed948e71f30 xmp.did:b8b627b9-63dc-f348-9625-1ed948e71f30 uuid:5D20892493BFDB11914A8590D31508C8 d … Adobe PDF library 16.07 endstream endobj 8519 0 obj > endobj 8520 0 obj >stream application/pdf Eli lilly Logo 2022-08-30T13:41:59-04:00 2022-08-30T13:41:59-04:00 2022-08-30T13:41:59-04:00 Adobe Illustrator 26.3 (Windows) uuid:3f28006f-8ff8-45eb-9aae-4be6f7eceea3 xmp.did:361a8268-9583-8a4f-92ab-b9350d09be3d uuid:5D20892493BFDB11914A8590D31508C8 p
Asset->js('assets/js/cookie-banner', null, false) }}" as="script">--> --> Venture Life Group extends distribution agreements with Elpen | AIM:VLG @ element('Front/sign_in_out_buttons') --> UK UK USA AU CA Watch --> My Proactive Feed Alerts Subscriptions Bookmarks Settings Sign In News Browse Latest news Contributors Live Market reports OTC Markets RNS Small caps FTSE 100 Live: Blue-chips cut losses, Downing Street pushes defence plan 17:05 26 Jun --> UK defence investors unmoved as Starmer prepares extra £1bn of spending 15:44 26 Jun --> My Pension Expert mooted sale and the read-across … ive's Stephen Gunnion to discuss the company's recent run of industry award wins, including recognition for AI-driven improvements in collections and Advantage Finance being named Car Finance Provider of the Year. Coombs explained how... 13 hours, 19 minutes ago Health 4basebio CEO on disrupting the $3bn DNA market with synthetic... 13 hours, 54 minutes ago Energy Chariot CEO on Angola deal transforming the company - One2One... 16 hours, 29 minutes ago Mining Serval
Dr Samrah Ahmed – School of Psychology and Clinical Language Sciences Skip to main content This site may not work correctly on Internet Explorer. We recommend switching to a different browser for a better experience. University of Reading Home School of Psychology and Clinical Language Sciences Undergraduate Psychology degrees How you'll study psychology Speech and language therapy degree How you'll study speech and language therapy Why study your degree with us? School life for undergraduates Undergraduate stories Laura Nicholson Leyla Owen Registered Intermediaries Shannon Smith-Whel … hy study a PhD with us? PhD fees and funding How we support PhD students How to apply for a PhD School life for PhD students Research stories CBT training Our research Research impact Research environment Open science Our staff Clinics and centres Work with us Alumni About us Equality and diversity Our committee Athena SWAN Policies and useful links Flexible working Parental leave Outreach Global Partnerships Undergraduate Psychology degrees How you'll study psychology Sp … hy study a PhD with us? PhD fees and funding How we support PhD students How to apply for a PhD School life for PhD students Research stories CBT training Our research Research impact Research environment Open science Our staff Clinics and centres Work with us Alumni About us Equality and diversity Our committee Athena SWAN Policies and useful links Flexible working Parental leave Outreach Global Partnerships School of Psychology and Clinical Language Sciences > Our staff
NeuroAge raises €10M for AI Alzheimer's detection, TheraCore gets £18M for digital therapies | Sanjay Gohil posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By click … y & community, What the Health, and head up Community at Healthtech Venture fund, Tenmile. 💜 Like this? Follow along for more or join >9700 legends getting the latest health innovation news direct to your inbox, by subscribing to our newsletter linked in the comments! 📩 104 4 Comments Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in John Quattrochi, DC 8mo Report this post Women's Health in MedTech: Source: “Women’s health: breakthrough m … is expected to open in early November 2025 and will be open for four weeks. The application process and questions are the same as for previous competitions. Sign up to the health newsletter to stay in the loop - https://ow.ly/Cyvh50XbM0k Read the full story about today’s winners announcement here - https://ow.ly/Ghbb50XbLYT 85 6 Comments Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Vishal Menon 8mo Report this post Thrilled to share some excit … me exciting news from Laverock Therapeutics ! We’ve been awarded an Innovate UK grant to further develop our programmable gene-silencing platform and macrophage-based therapies for hard-to-treat cancers. Read more: https://lnkd.in/dCj4w6SZ #Biotech #CellTherapy #MacrophageTherapy #GeneSilencing #SyntheticBiology #CancerResearch #InnovateUK #LaverockTherapeutics Innovate UK 175,813 followers 8mo Edited 📣 Day three of Biomedical Catalyst week is exciting, as we announce more i … is expected to open in early November 2025 and will be open for four weeks. The application process and questions are the same as for previous competitions. Sign up to the health newsletter to stay in the loop - https://ow.ly/Cyvh50XbM0k Read the full story about today’s winners announcement here - https://ow.ly/Ghbb50XbLYT 10 Like Comment Share
Dr. Goodenowe, Plasmalogens, and the Cholesterol “Scam” | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Dr. Goodenowe, Plasmalogens, and the Cholesterol “Scam” What the evidence actually says about this popular supplement scientist Dr. Christin Glorioso, MD PhD February 7, 2026 11 min read I’ve been getting a lot of questions about Dr. Dayan Goodenowe and his plasmalogen supplements. His podcast appearances are everywhere. His book “Breaking Alzheimer’s” has a devoted fol … odenowe’s supplement study failed to file the required Investigational New Drug application, which would have required animal testing data showing the study wouldn’t expose subjects to unnecessary risks. The FDA wrote that this failure “raises significant concerns about the safety and welfare of enrolled subjects” and “raises concerns about the validity and integrity of the data collected.” Multiple investigations are now underway. The Moose Jaw Police Service launched a crim … conspiratorial framing (”scam,” “ALS drug industry”) to deflect criticism, and apply findings from specific populations to general recommendations. If you’re considering plasmalogens for general brain health, know that you’re in uncharted territory. The clinical evidence is weak. The safety data at high doses is absent. The cost is high. And please don’t substitute them for evidence-based cardiovascular risk management. Your brain needs good blood flow. If you or a loved one
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
The future of medicine is invisible, frictionless, AI-matched, continuous, and at home | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog The future of medicine is invisible, frictionless, AI-matched, continuous, and at home This is not only going to be nice, it's also going to save us a lot of money Dr. Christin Glorioso, MD PhD May 3, 2026 26 min read It is a Tuesday in 2036. The toilet has already finished a microbiome read and a urine analysis while I brushed my tee
Some VCs have told me to “pick a lane”, here’s why I think this is fundamentally wrong | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Some VCs have told me to “pick a lane”, here’s why I think this is fundamentally wrong Diagnostics and therapeutics were separated by accident, and pharma is now spending billions to put them back together Dr. Christin Glorioso, MD PhD May 15, 2026 15 min read The “pick a lane” rule in biotech, where companies focus on either diagnostics o
Can Flickering Lights and Clicking Sounds Protect Your Brain from Alzheimer’s? | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Can Flickering Lights and Clicking Sounds Protect Your Brain from Alzheimer’s? Reviewing the evidence for 40 Hz devices Dr. Christin Glorioso, MD PhD March 10, 2026 18 min read A growing number of consumer devices now claim to boost brain health by delivering light and sound at a specific frequency, 40 Hz, or 40 cycles per second. The science behi
Nootropic Properties of Nicotine (without the smoke). | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Nootropic Properties of Nicotine (without the smoke). Why I'm Still Bullish on This Molecule Dr. Christin Glorioso, MD PhD February 27, 2026 12 min read I used to smoke cigarettes. I loved nicotine, the ritual 5 minute breaks outside, the social aspect of smoking with friends. Smoking and drinking coffee was a great combo for studying non-stop, which as a pre-med and
Are We Actually Aging More Slowly Than Our Parents Did? | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Are We Actually Aging More Slowly Than Our Parents Did? Dr. Christin Glorioso, MD PhD March 7, 2026 17 min read Ricky Martin is 54 years old. Kristen Wiig is 52. If you’ve been watching them on Apple TV’s Palm Royale , set in the glittering excess of 1960s Palm Beach, you might find those numbers hard to believe. Martin looks like he could still be headlining the 1999 G
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
Neurocognitive Study for the Aging-a Longitudinal Study With a Greek Cypriot Cohort | Clinical Research Trial Listing CenterWatch Skip to content Search Clinical Trials Clinical Trial Listings Volunteer Learn About Clinical Trials Home Search Study Summary Eligibility Criteria Study Design Study Description Study Centers Disclaimer Neurocognitive Study for the Aging-a Longitudinal Study With a Greek Cypriot Cohort Last updated: August 21, 2023 Sponsor: University of Cyprus Overall Status: Active - Recruiting Phase N/A Condition Memory Problems Alzheimer's Disease Mental Disability Read more ex … and has received subsequent funding by the European Union Regional Development Fund. The project focuses on the understanding of the effects of age on neurocognitive abilities such as attention, memory, language, categorization, and executive functioning. In addition, specific arms of the project investigate the effects of a theory-driven hierarchical training program, the Categorization Program, to improve cognitive abilities in adults with Mild Cognitive Impairment (MCI) a … lts ages 40 and older have been recruited in the NEUROAGE project thus far. The grant was awarded to the University of Cyprus, with Professor Fofi Constantinidou as the PI. Eligibility Criteria Inclusion Inclusion Criteria: healthy with no prior neurological history Exclusion Exclusion Criteria: prior neurological history or significant psychiatric history Study Design Total Participants: 1000 Treatment Group(s): 2 Primary Treatment: Categorization training Phase: Study Start
Hello World! - LONGEVITY GLOBAL Skip to content LONGEVITY GLOBAL SF | NYC | UAE | BOS | SD | ATX | CO | HYD | CHI | LON | PHX | LA | DEU Menu + × expanded collapsed Events Calendar of longevity events Brain Optimization Summit 2026 Longevity Global Summit 2026 AI x Longevity Summit (NYC) Aging Code Summit 2026 Longevity Innovation Forum (SD) Event Photos Community Become a member Community Chapters Longevity CO Longevity SF Longevity SD Longevity NYC Longevity BOS Longevity Global ATX Longevity CHI Longevity MEL Longevity DEU Longevity LON Resources About Substack YouTube Discount Market
Dr. Christin Glorioso - AgeTech at CES VENETIAN EXPO, LEVEL 2, HALLS A-D | BOOTH #54123 | JAN 6-9, 2026, LAS VEGAS, NV VENETIAN EXPO LEVEL 2, HALLS A-D BOOTH #54123 | JAN 7-10, 2025, LAS VEGAS, NV Home Videos Speakers Startups Experiences Connect Home Videos Speakers Startups Experiences Connect All Speakers Dr. Christin Glorioso CEO and Co-Founder, NeuroAge Therapeutics Dr. Christin Glorioso is a neuroscientist, physician, and serial entrepreneur. She is Co-Founder and CEO of NeuroAge Therapeutics and Founder and Executive Director of the non-profit, Longevity Global. Previously she was Head … growing network of stakeholders in the AgeTech ecosystem Apply Today Home Videos Speakers Startups Experiences Connect Home Videos Speakers Startups Experiences Connect Terms of Service | Privacy Policy © 2026 AARP. All Rights Reserved Instagram Linkedin Search
Reaction time training improves brain health and lowers dementia risk by ~30% | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Reaction time training improves brain health and lowers dementia risk by ~30% The evidence for and amount of reaction time training to optimize cognition Dr. Christin Glorioso, MD PhD July 26, 2025 5 min read I am regularly asked about whether cognitive training is beneficial for brain health and dementia prevention. While not all cognitive trainin
Both of these will be fantastic - includes Neuroage brain aging tests also | Ronjon Nag LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’
NeuroAge Therapeutics Launches Younger 2027 Back to lifespan Home Login Return to Lifespan Homepage Donate Login News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep Diet Financial Blockchain Investing Advocacy Policy Public Outreach LRI News Interviews Op-Ed Editorial Editor’s Pick Rejuvenation Roundup Press Releases News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep Diet Financ … S, Humanaut Health, and Prime Health Associates. Prizes and Awards Younger 2027 award categories include: The Younger Award (most years of biological age turned back) The Forever Young Award (youngest biological age relative to chronological age) The Ultra Younger Award (most years turned back on the Ultra panel) The Ultra Forever Young Award (youngest biological age on the Ultra panel) Organ-system category winners Sponsoring partners contribute a $50,000 equivalent prize po
Do rapamycin and exercise combine to improve function and reduce biological age? | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Do rapamycin and exercise combine to improve function and reduce biological age? New study results from Dr. Matt Kaeberlein and Dr. Brad Stanfield Dr. Christin Glorioso, MD PhD April 28, 2026 13 min read Rapamycin is a darling drug of longevity enthusiasts. It has shown consistent lifespan extension in mice across multiple independent laboratori
Controlled Christin Glorioso, MD PHD and NeuroAge Therapeutics joined us at the XPRIZE Healthspan Milestone 1 Awards and Summit! Excellent work and resources for our teams. Super proud and excited to… | Jamie Justice, Ph.D. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your ch … oAge Therapeutics reached the semifinal category of the XPRIZE healthspan $101m prize as part of the R42 Group portfolio team. 27 2 Comments Like Comment Share Copy LinkedIn Facebook X Christin Glorioso, MD PHD 1y Report this comment Thanks Jamie! This was a really great event. I was very inspired by the interventions showcased. Like Reply 1 Reaction 2 Reactions Ronjon Nag 1y Report this comment Love this, Jamie and Christin Like Reply 1 Reaction See more comme
Meet the scientists behind NeuroAge | Our mission & team Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login A personal commitment to fighting brain aging NeuroAge was founded from a deep personal connection to fighting brain aging. Dr. Christin Glorioso's grandmother passed away from Alzheimer’s disease when she was a child. She witnessed the suffering that brought to her grandmother and to her loved ones. Since that time, she has had a lifelong commitment to creating better therapies to preven
Do Cognitive Training Games Improve Brain Health? | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Do Cognitive Training Games Improve Brain Health? Dr. Christin Glorioso, MD PhD November 25, 2025 9 min read Cognitive training games were once very popular and then received bad press for lacking evidence. This included a lawsuit aimed at Lumosity in 2016 for making claims that were not backed up by science. Since then, the evidence has been mounting and we have learned a lo
The New York Times Called Galleri a Failed Test. I Think They Got It Wrong. | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog The New York Times Called Galleri a Failed Test. I Think They Got It Wrong. Dr. Christin Glorioso, MD PhD February 24, 2026 13 min read I took my first Grail Galleri multi-cancer detection test this year in preparation for helping with the R42 Group Longevity Retreat. I think this test is worthwhile for the peace of mind it brings. Also, anecdotally, … gh very few insurers cover it. Grail submitted its FDA premarket approval (PMA) application in January 2026. Understanding the Test’s Accuracy These numbers are central to the debate about whether Galleri is ready for widespread use. Sensitivity refers to the test’s ability to correctly identify people who actually have cancer. In the PATHFINDER 2 study (35,878 participants, results presented at ESMO 2025 ), Galleri’s overall sensitivity across all cancer types was 40.4%. For
The micronutrient essential for brain health that 90 percent of people don't get enough of | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog The micronutrient essential for brain health that 90 percent of people don't get enough of What choline does for the aging brain, how much you need, why it is hard to test, the foods that supply it, the APOE4 angle, and when a supplement makes sense Dr. Christin Glorioso, MD PhD June 20, 2026 16 min read Last week I went thro
NeuroAge Therapeutics was featured in an article in the New Scientist this week: | Christin Glorioso, MD PHD LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, y
AI Insiders: Healthcare & Biotech · Luma Discover Events Sign In Presented by AI Insiders Follow AI Insiders is an invite-only intelligence network where founders, operators, and investors shape the future of AI across six verticals. Apply for partnerships: aiinsiders.us Hosted By Merve Isler Ronjon Nag Bailee Nasise Anna Lindfors Marvelous 106 Went Kristopher Floyd, Kevin Yar and 104 others Contact the Host Refund Policy Report Event AI Insiders: Healthcare & Biotech AI Insiders Verizon Innovation Lab (360 Spear St) Get Tickets Past Event Welcome! Please choose your desired ticket typ … edicine ) Serial inventor, investor, winner of the $1M Verizon Powerful Answers Award. 4:30 PM – 5 Startups Defining the Future of AI in Healthcare & Biotech Cosmica AI, David Furman , Founder Icarus Therapeutics, Nate Hughes , Jack Owens , Founders Oxford Drug Design, Alan Roth , CEO Aikium, Eswar Iyer , Co-Founder NeuroAge Therapeutics, Christin Glorioso , Founder Audience vote: Most Deployable, Most Investable, Most Game-Changing 5:00 – Panel Discussio … by Apple, BlackBerry, and Motorola, and he won the $1M Verizon Powerful Answers Award. Dr. Martin Kawalski (Stanford) is an MD/PhD sleep medicine researcher studying how consumer wearables measure sleep disruption’s impact on aging, and how AI can improve patient education and engagement. Max Marchione (Superpower), Co-founder and CEO, is building a new healthcare system focused on preventing disease and enhancing human capability. Ayah Hamdan (Plug & Play) is a hea … founders, operators, and investors shape the future of AI across six verticals. Apply for partnerships: aiinsiders.us Hosted By Merve Isler Ronjon Nag Bailee Nasise Anna Lindfors Marvelous 106 Went Kristopher Floyd, Kevin Yar and 104 others Contact the Host Refund Policy Report Event Discover Pricing Help Get the App
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
NeuroAge Therapeutics featured in Stat News article on Vitalist Bay. Body scans, blood tests, and bodyoids Most people in the longevity community are focused on preserving their health as long as… | Christin Glorioso, MD PHD LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your c … lab focused on disease biology and brain health, joining a growing movement to apply advanced artificial intelligence to biomedical discovery. Human Longevity, Inc. Longevity Inc. has launched a new entity dedicated to building AI-powered health models, reflecting increasing convergence between large-scale health data and predictive analytics. Scribe Therapeutics reported up to 68% LDL-C reduction with a single-dose epigenetic therapy, highlighting the potential of next-gene … are Copy LinkedIn Facebook X To view or add a comment, sign in Cure Alzheimer's Fund 3,214 followers 3w Edited Report this post We’re excited to see CureAlz-supported research continuing to shed light on how exercise benefits the brain. Dr. Christiane Wrann ’s earlier work demonstrated that the hormone irisin, released from muscles during physical activity, plays a pivotal role in brain health by potentially mitigating a hallmark feature of Alzheimer's disease—the accumulatio
The NeuroAge Therapeutics team is at Vitalist Bay in Berkeley! 🧠 Excited to see more conversations around prevention, cognitive longevity, and empowering people to learn more about their brain… | Marah Doria LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any ti
Peptides for Cognitive Enhancement & Dementia Prevention | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog Peptides for Cognitive Enhancement & Dementia Prevention A review of popular peptides including GLP1-RAs, SS-31, BPC-157, and Cerebrolysin Dr. Christin Glorioso, MD PhD December 20, 2025 22 min read The global peptide therapeutics market was estimated at a whopping $117B in 2024 and is continuing to grow. The leading edge of that market is driven by popular pep … . Time to progression to dementia was also unaffected. Why This Failure May Not Apply to Prevention 1. The Epidemiological Signal Points to Prevention, Not Treatment Real-world data from over 1 million patients with type 2 diabetes consistently shows that semaglutide users have 40-70% lower risk of first-time Alzheimer’s diagnosis compared to other diabetes medications . This signal suggests influence on early pathogenic processes rather than established neurodegeneration. As … Asia. The reasons for its absence from the US market are multifactorial: No FDA Application Filed: Ever Neuro Pharma, the Austrian manufacturer, has not pursued FDA approval. The FDA does not proactively approve drugs—companies must submit New Drug Applications with Phase 1-3 trial data meeting FDA standards. Without a sponsor willing to invest in US trials, approval cannot occur. Inconsistent Trial Results: While dementia trials show benefit, the CASTA stroke trial failure a
NeuroAge Therapeutics | Alzheimer's Drug Discovery Foundation Donate Email Sign Up Search Search Submit Twitter Facebook YouTube Linkedin About Us Our Founders Staff Leadership Young Professionals Committee Our Impact Our Partners Annual Reports & Financials Careers Alzheimer's Disease What is Alzheimer's? Alzheimer's Causes Diagnosis & Treatment Alzheimer's Prevention Patient & Family Resources Research Our Research Strategy Funding Opportunities COVID-19 FAQ Diagnostics Accelerator SpeechDx Goodes Prize Our Portfolio Portfolio Highlights Reporting For Funded Projects ADDF Reports Events & … Conditions Privacy Policy Close DONATE SIGN UP Twitter Facebook YouTube Search* Submit About Us Our Founders Staff Leadership Young Professionals Committee Our Impact Our Partners Annual Reports & Financials Careers Alzheimer's Disease What is Alzheimer's? Alzheimer's Causes Diagnosis & Treatment Alzheimer's Prevention Patient & Family Resources Research Our Research Strategy Funding Opportunities Diagnostics Accelerator Melvin R. Goodes Prize
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
How old is your brain? | AI cognitive testing - NeuroAge Therapeutics Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login HSA/FSA eligible Measure your brain age. Become optimally sharp. NeuroAge combines cognitive testing, AI, and advanced diagnostics to help you track brain health. Our brain training program and personalized recommendations are designed to help you become your sharpest self. Find the right test for you Validated on data from 500,000+ individuals Supported by dozens of peer-reviewed pub … d formerly Chief Strategist at the Bakar Aging Research Institute at UCSF. ADDF grant recipient, and author of 30+ peer-reviewed publications. Alzheimer's affected her own family. That personal mission shaped NeuroAge's core purpose. Meet the team HSA/ FSA eligible Every way to assess your brain health NeuroAge offers multi-modal testing that measures brain aging and dementia risk from different angles. You can combine tests or start with one. Not sure what to choos
APOE and Alzheimer's | NeuroAge Blog Have an Alzheimer's or MCI diagnosis? Receive a free test by participating in our study → Resources Products Events Partnering Demo Login Back to Blog APOE and Alzheimer's Understanding the most common Alzheimer's risk gene and what to do about it Dr. Christin Glorioso, MD PhD July 5, 2025 11 min read I was sitting in NeuroAge’s headquarters when I decided to “rip the bandaid off” and look at my genetic risk for Alzheimer’s Disease. I had been putting it off because I had for most of my life thought that there wasn’t much I could do abou